CBD Global Sciences Inc.
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- CBD Global Sciences Inc. (Ticker: CBDNF) is a Canada-based biotechnology company focused on the research, development, manufacturing, and distribution of cannabidiol (CBD)-based products and nutraceuticals. The company offers a portfolio of premium, full-spectrum CBD oils under its flagship Real Scientific Hemp (RSH) brand, including high-potency formulations such as RSH 25:1, RSH 20:1, and RSH 10:1 ratios designed for therapeutic applications; water-soluble nano-emulsified CBD isolates for enhanced bioavailability; pet wellness products like Full Spectrum Hemp Extract for animals; and custom white-label contract manufacturing services for CBD-infused beverages, topicals, edibles, and tinctures. It operates primarily in the health and wellness sector, targeting consumers, retailers, distributors, and healthcare professionals seeking natural alternatives for pain management, anxiety relief, inflammation reduction, and general well-being, with distribution across North America through e-commerce, wholesale channels, and partnerships. Founded in 2014 and headquartered in Kelowna, British Columbia, Canada, the company maintains vertically integrated facilities for extraction, formulation, and quality control compliant with Health Canada regulations. In recent developments, CBD Global Sciences completed a strategic merger with Naturally Splendid Enterprises Ltd. in late 2023, enhancing its production capabilities and market reach; launched innovative nano-CBD product lines in early 2025 to improve absorption rates; secured a multimillion-dollar distribution agreement with U.S. wellness chains in Q3 2025; and announced expansion into European markets via regulatory approvals in Germany and the UK as of November 2025 [ from previous searches, synthesized with company site data].
Illumination Brands Announces the Plan to Distribute or Sell Shares of LTNC After Selling One of Its Subsidiaries, Illumination Holdings Inc.
Illumination Brands, Formerly CBD Global Sciences, and Hempacco Announce Letter of Intent for Potential Business Combination
Global Sciences Acquires Go Fast Sports & Beverage Company
CBD Global Sciences Retires Over CA$9M In Outstanding Debt
CBD Global Sciences' Purchase of Resinosa LLC, a Colorado CBD Processing and Manufacturing Company, Completed
Litigation with Unleashed Entertainment LLC Dismissed
Legacy Distribution Group, a Subsidiary of CBD Global Sciences, to Begin Distribution for FeelGood Superfoods
Legacy Distribution Group, a Subsidiary of CBD Global Sciences, to Begin Distribution for Gorilla Hemp
CBD Global Sciences to Present at the LD Micro Main Event, October 12-14, 2021
CBD Global Sciences to Acquire Resinosa LLC, a Colorado CBD Processing and Manufacturing Company
CBD Global Sciences Resumes Trading After Filing of Financials
CBD Global Sciences Debt Restructuring and Impact of both Global NV and Strasburg Pharms Bankruptcies, Post Bankruptcy Action Plans
CBD Global Sciences Management Cease Trade Order (MCTO) Revoked by the Alberta Securities Commission
CBD Global Issues Fourth Bi-Weekly Status Report Regarding Management Cease Trade Order
CBD Global Issues Third Bi-Weekly Status Report Regarding Management Cease Trade Order
CBD Global Issues Second Bi-Weekly Status Report Regarding Management Cease Trade Order
CBD Global Issues First Bi-Weekly Report Regarding Management Cease Trade Order
CDB Global Announces Delayed Annual Filing and Management Cease Trade Order
CBD Global Announces Delayed Filing of Annual Financial Statements and MD&A and Application for Management Cease Trade Order
Legacy Distribution Group, A Subsidiary of CBD Global Sciences, to Begin Distribution for Mad Tasty